Publikace
- Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions2022 | 2. lékařská fakulta
- Characterization of 46 patient-specific BCR-ABL1 fusions and detection of SNPs upstream and downstream the breakpoints in chronic myeloid leukemia using next generation sequencing2015 | 1. lékařská fakulta, 2. lékařská fakulta
- Posttreatment positivity of BCR::ABL1 in acute lymphoblastic leukemia: Should we keep track?2023 | 2. lékařská fakulta
- Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy2022 | 2. lékařská fakulta
- Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease2022 | 2. lékařská fakulta
- Analysis of chronic myeloid leukaemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remission2020 | 1. lékařská fakulta, 2. lékařská fakulta
- Metabolic profile of leukemia cells influences treatment efficacy of L-asparaginase2020 | 2. lékařská fakulta
- ERG deletions in childhood acute lymphoblastic leukemia with DUX4 rearrangements are mostly polyclonal, prognostically relevant and their detection rate strongly depends on screening method sensitivity2019 | 2. lékařská fakulta
- Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology2017 | 2. lékařská fakulta
- Slower early response to treatment and distinct expression profile of childhood high hyperdiploid acute lymphoblastic leukaemia with DNA index < 1.162016 | 2. lékařská fakulta
Loading network view...